Reinforcing Effects of Stimulants in Humans: Sensitivity of Progressive-Ratio Schedules

Experimental and Clinical Psychopharmacology

Volumn 16, Issue 6, 2008, Pages 503-512

  Stoops, William W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

drug reinforcement; humans; progressive ratio; stimulant

Indexed keywords

AMPHETAMINE; BACLOFEN; BUPRENORPHINE; COCAINE; DEXAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; NICOTINE; PENTOBARBITAL; PERGOLIDE; PLACEBO;

ARTICLE; CARDIOVASCULAR EFFECT; CIGARETTE SMOKING; COCAINE DEPENDENCE; DEPRESSION; DOSE RESPONSE; DRUG ABUSE; DRUG SELF ADMINISTRATION; HUMAN; OBESITY; REINFORCEMENT; REWARD; TASK PERFORMANCE; VOLUNTEER;

CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; REINFORCEMENT SCHEDULE; RESEARCH DESIGN; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 57949105772     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0013657     Document Type: Article

References (65)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (2000), Author, Washington, DC
2. Arria A.M., Caldeira K.M., O'Grady K.E., Vincent K.B., Johnson E.P., and Wish E.D. Nonmedical use of prescription stimulants among college students: Associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy 28 (2008) 156-169
3. Arria A.M., and Wish E.D. Nonmedical use of prescription stimulants among students. Pediatric Annals 35 (2006) 565-571
4. Comer S.D., Ashworth J.B., Foltin R.W., Johanson C.E., Zacny J.P., and Walsh S.L. The role of human drug self-administration procedures in the development of medications. Drug and Alcohol Dependence 96 (2008) 1-15
5. Comer S.D., Collins E.D., MacArthur R.B., and Fischman M.W. Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology 143 (1999) 327-338
6. Comer S.D., Haney M., Foltin R.W., and Fischman M.W. Amphetamine self-administration by humans: Modulation by contingencies associated with task performance. Psychopharmacology 127 (1996) 39-46
7. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., and O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30 (2005) 205-211
8. Dar R., and Frenk H. Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology 173 (2004) 18-26
9. de Wit H., Uhlenhuth E.H., and Johanson C.E. The reinforcing properties of amphetamine in overweight subjects and subjects with depression. Clinical Pharmacology and Therapeutics 42 (1987) 127-136
10. Donny E.C., Bigelow G.E., and Walsh S.L. Choosing to take cocaine in the human laboratory: Effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement. Drug and Alcohol Dependence 69 (2003) 289-301
11. Donny E.C., Bigelow G.E., and Walsh S.L. Assessing the initiation of cocaine self-administration in humans during abstinence: Effects of dose, alternative reinforcement, and priming. Psychopharmacology 172 (2004) 316-323
12. Evans S.M., and Griffiths R.R. Caffeine tolerance and choice in humans. Psychopharmacology 108 (1992) 51-59
13. Fischman M.W., and Johanson C.E. Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers. Behavioural Pharmacology 9 (1998) 479-498
14. Fischman M.W., and Schuster C.R. Cocaine self-administration in humans. Federation Proceedings 41 (1982) 241-246
15. Focchi G.R., Leite M.C., Andrade A.G., and Scivoletto S. Use of dopamine agonist pergolide in outpatient treatment of cocaine dependence. Substance Use and Misuse 40 (2005) 1169-1177
16. Foltin R.W., and Fischman M.W. Assessment of abuse liability of stimulant drugs in humans: A methodological survey. Drug and Alcohol Dependence 28 (1991) 3-48
17. Foltin R.W., and Fischman M.W. Effects of buprenorphine on the self-administration of cocaine by humans. Behavioural Pharmacology 5 (1994) 79-89
18. Gardner E.L. What we have learned about addiction from animal models of drug self-administration. American Journal on Addictions 9 (2000) 285-313
19. Grabowski J., Rhoades H., Schmitz J., Stotts A., Daruzska L.A., Creson D., and Moeller F.G. Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial. Journal of Clinical Psychopharmacology 21 (2001) 522-526
20. Grabowski J., Shearer J., Merrill J., and Negus S.S. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors 29 (2004) 1439-1464
21. Griffiths R.R., Bigelow G.E., and Ator N.A. Principles of initial experimental drug abuse liability assessment in humans. Drug and Alcohol Dependence 70 3, Suppl. 1 (2003) S41-S54
22. Griffiths R.R., Bigelow G.E., and Henningfield J.E. Similarities in animal and human drug taking behavior. In: Mello N.K. (Ed). Advances in substance abuse: Behavioral and biological research (1980), JAI Press, Greenwich, CT 1-90
23. Griffiths R.R., Bigelow G.E., and Liebson I.A. Reinforcing effects of caffeine in coffee and capsules. Journal of the Experimental Analysis of Behavior 52 (1989) 127-140
24. Griffiths R.R., Brady J.V., and Bradford L.D. Predicting the abuse liability of drugs and animal drug self-administration procedures: Psychomotor stimulants and hallucinogens. In: Thompson T., and Dews P.B. (Eds). Advances in behavioral pharmacology 2 (1979), Academic Press, New York 163-208
25. Haney M., Foltin R.W., and Fischman M.W. Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology 137 (1998) 15-24
26. Haney M., Hart C.L., and Foltin R.W. Effects of baclofen on cocaine self-administration: Opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology 31 (2006) 1814-1821
27. Haney M., and Spealman R. Controversies in translational research: Drug self-administration. Psychopharmacology 199 (2008) 403-419
28. Harakeh Z., Engels R.C., Van Baaren R.B., and Scholte R.H. Imitation of cigarette smoking: An experimental study on smoking in a naturalistic setting. Drug and Alcohol Dependence 86 (2007) 199-206
29. Hart C.L., Haney M., Vosburg S.K., Rubin E., and Foltin R.W. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33 (2008) 761-768
30. Hart C.L., Ward A.S., Haney M., Foltin R.W., and Fischman M.W. Methamphetamine self-administration by humans. Psychopharmacology 157 (2001) 75-81
31. Henningfield J.E., Cohen C., and Heishman S.J. Drug self-administration methods in abuse liability evaluation. British Journal of Addiction 86 (1991) 1571-1577
32. Henningfield J.E., Lukas S.E., and Bigelow G.E. Human studies of drugs as reinforcers. In: Goldberg S.R., and Stolerman I.P. (Eds). Behavioral analysis of drug dependence (1986), Academic Press, Orlando, FL 69-122
33. Herman-Stahl M.A., Krebs C.P., Kroutil L.A., and Heller D.C. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25. Addictive Behaviors 32 (2007) 1003-1015
34. Higgins S.T., Alessi S.M., and Dantona R.L. Voucher-based incentives. A substance abuse treatment innovation. Addictive Behaviors 27 (2002) 887-910
35. Higgins S.T., Bickel W.K., and Hughes J.R. Influence of an alternative reinforcer on human cocaine self-administration. Life Sciences 55 (1994) 179-187
36. Hodos W. Progressive-ratio as a measure of reward strength. Science 134 (1961, September 29) 943-944
37. Johanson C.E., Kilgore K., and Uhlenhuth E.H. Assessment of dependence potential of drugs in humans using multiple indices. Psychopharmacology 81 (1983) 144-149
38. Johanson C.E., and Uhlenhuth E.H. Drug preference and mood in humans: d-amphetamine. Psychopharmacology 71 (1980) 275-279
39. Malcolm R., Kajdasz D.K., Herron J., Anton R.F., and Brady K.T. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug and Alcohol Dependence 60 (2000) 161-168
40. McCabe S.E., Teter C.J., and Boyd C.J. Medical use, illicit use and diversion of prescription stimulant medication. Journal of Psychoactive Drugs 38 (2006) 43-56
41. McLeod D.R., and Griffiths R.R. Human progressive-ratio performance: Maintenance by pentobarbital. Psychopharmacology 79 (1983) 4-9
42. Mitchell S.H., Laurent C.L., and de Wit H. Interaction of expectancy and the pharmacological effects of d-amphetamine: Subjective effects and self-administration. Psychopharmacology 125 (1996) 371-378
43. Montoya I.D., Gorelick D.A., Preston K.L., Schroeder J.R., Umbricht A., Cheskin L.J., et al. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clinical Pharmacology and Therapeutics 75 (2004) 34-48
44. Myrick H., Malcolm R., Taylor B., and LaRowe S. Modafinil: Preclinical, clinical, and post-marketing surveillance-A review of abuse liability issues. Annals of Clinical Psychiatry 16 (2004) 101-109
45. Novak S.P., Kroutil L.A., Williams R.L., and Van Brunt D.L. The nonmedical use of prescription ADHD medications: Results from a national Internet panel. Substance Abuse Treatment, Prevention, and Policy 2 (2007) 32
46. Pickens R., and Thompson T. Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size. Journal of Pharmacology and Experimental Therapeutics 161 (1968) 122-129
47. Richardson N.R., and Roberts D.C. Progressive-ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy. Journal of Neuroscience Methods 66 (1996) 1-11
48. Roehrs T., Johanson C.E., Meixner R., Turner L., and Roth T. Reinforcing and subjective effects of methylphenidate: Dose and time in bed. Experimental and Clinical Psychopharmacology 12 (2004) 180-189
49. Rush C.R., Essman W.D., Simpson C.A., and Baker R.W. Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. Journal of Clinical Psychopharmacology 21 (2001) 273-286
50. Rusted J.M., Mackee A., Williams R., and Willner P. Deprivation state but not nicotine content of the cigarette affects responding by smokers on a progressive-ratio task. Psychopharmacology 140 (1998) 411-417
51. Shahan T.A., Bickel W.K., Badger G.J., and Giordano L.A. Sensitivity of nicotine-containing and de-nicotinized cigarette consumption to alternative non-drug reinforcement: A behavioral economic analysis. Behavioural Pharmacology 12 (2001) 277-284
52. Shahan T.A., Bickel W.K., Madden G.J., and Badger G.J. Comparing the reinforcing efficacy of nicotine containing and de-nicotinized cigarettes: A behavioral economic analysis. Psychopharmacology 147 (1999) 210-216
53. Shoptaw S., Yang X., Rotheram-Fuller E.J., Hsieh Y.C., Kintaudi P.C., Charuvastra V.C., and Ling W. Randomized placebo-controlled trial of baclofen for cocaine dependence: Preliminary effects for individuals with chronic patterns of cocaine use. Journal of Clinical Psychiatry 64 (2003) 1440-1448
54. Sigmon S.C., Tidey J.W., Badger G.J., and Higgins S.T. Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money. Psychopharmacology 167 (2003) 393-402
55. Silverman K., Kirby K.C., and Griffiths R.R. Modulation of drug reinforcement by behavioral requirements following drug ingestion. Psychopharmacology 114 (1994) 243-247
56. Spiga R., and Roache J.D. Human drug self-administration: A review and methodological critique. In: Johnson B.A., and Roache J.D. (Eds). Drug addiction and its treatment: Nexus of neuroscience and behavior (1997), Lippincott-Raven, Philadelphia 39-71
57. Stafford D., LeSage M.G., and Glowa J.R. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: A review. Psychopharmacology 139 (1998) 169-184
58. Stoops W.W., Glaser P.E., Fillmore M.T., and Rush C.R. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. Journal of Psychopharmacology 18 (2004) 534-543
59. Stoops W.W., Lile J.A., Fillmore M.T., Glaser P.E., and Rush C.R. Reinforcing effects of methylphenidate: Influence of dose and behavioral demands following drug administration. Psychopharmacology 177 (2005) 349-355
60. Stoops W.W., Lile J.A., Fillmore M.T., Glaser P.E., and Rush C.R. Reinforcing effects of modafinil: Influence of dose and behavioral demands following drug administration. Psychopharmacology 182 (2005) 186-193
61. Stoops W.W., Lile J.A., Robbins C.G., Martin C.A., Rush C.R., and Kelly T.H. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: Influence of sensation-seeking status. Addictive Behaviors 32 (2007) 1177-1188
62. Stoops W.W., Vansickel A.R., Lile J.A., and Rush C.R. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacology, Biochemistry, and Behavior 87 (2007) 20-29
63. Substance Abuse & Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings (NSDUH Series H-32, DHHS Pub. No. SMA 07-4293) (2007), Author, Rockville, MD
64. Vocci F., and Ling W. Medications development: Successes and challenges. Pharmacology and Therapeutics 108 (2005) 94-108
65. Young A.M., and Herling S. Drugs as reinforcers: Studies in laboratory animals. In: Goldberg S.R., and Stolerman I.P. (Eds). Behavioral analysis of drug dependence (1986), Academic Press, Orlando, FL 67-99